Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Context: The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase-catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined. Case Description: We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434*); P1, P2: thyrotropin >100 µU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) <0.09 ng/dL (RR 0.9 to 2.3). Subsequent studies have revealed a homozygous DUOX1 mutation (c.1823-1G>C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs*43), which segregates with CH in this kindred. Conclusion: This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the first CH patients with both DUOX1 and DUOX2 mutations have been reported, suggesting that CH can have a digenic cause (225).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital Hypothyroidism
Moreno, J. C., Bikker, H., Kempers, M. J. E., van Trotsenburg, A. S. P., Baas, F., de Vijlder, J. J. M., Vulsma, T., & Ris-Stalpers, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012752 · Cited by 485 · cited 2×
“S965fsX994] are associated with CH or severely impaired H2O2-generating activity in vitro (4, 6, 7).”
BackgroundGenetic disorders coupled to ROS deficiency
O’Neill, S., Brault, J., Stasia, M.-J., & Knaus, U. G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.07.009 · Cited by 164
Maruo, Y., Takahashi, H., Soeda, I., Nishikura, N., Matsui, K., Ota, Y., Mimura, Y., Mori, A., Sato, H., & Takeuchi, Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0856 · Cited by 122 · cited 2×
“R434* DUOX2 mutation itself are contributing to disease severity (6, 8, 9) (Table 1).”
BackgroundNicholas, A. K., Serra, E. G., Cangul, H., Alyaarubi, S., Ullah, I., Schoenmakers, E., Deeb, A., Habeb, A. M., Almaghamsi, M., Peters, C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1879 · Cited by 112 · cited 2×
“In the wider CH context, next-generation sequencing technologies are elucidating a role for oligogenicity in disease pathogenesis (10).”
BackgroundSelf-citationCaenorhabditis elegans and Human Dual Oxidase 1 (DUOX1) “Peroxidase” Domains
Meitzler, J. L., & Ortiz de Montellano, P. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013581 · Cited by 86 · cited 1×
“In vitro evaluation of a similarly truncated DUOX1 isoenzyme comprising amino acids 1 to 593 alone abolished H2O2-generating activity (5).”
BackgroundMuzza, M., Rabbiosi, S., Vigone, M. C., Zamproni, I., Cirello, V., Maffini, M. A., Maruca, K., Schoenmakers, N., Beccaria, L., Gallo, F., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3618 · Cited by 83 · cited 2×
“No DUOX1-sequencing results are reported for other cases with permanent CH associated with biallelic truncating DUOX2mutations listed in Table 1, although variants in other CH-associated genes were occasionally sought (2, 6, 9, 10).”
BackgroundSelf-citationDe Marco, G., Agretti, P., Montanelli, L., Di Cosmo, C., Bagattini, B., De Servi, M., Ferrarini, E., Dimida, A., Freitas Ferreira, A. C., Molinaro, A., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2467 · Cited by 70 · cited 1×
“S965fsX994] are associated with CH or severely impaired H2O2-generating activity in vitro (4, 6, 7).”
BackgroundVarela, V., Rivolta, C. M., Esperante, S. A., Gruñeiro-Papendieck, L., Chiesa, A., & Targovnik, H. M. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.058321 · Cited by 66 · cited 3×
“S965fsX994] are associated with CH or severely impaired H2O2-generating activity in vitro (4, 6, 7).”
BackgroundFu, C., Luo, S., Zhang, S., Wang, J., Zheng, H., Yang, Q., Xie, B., Hu, X., Fan, X., Luo, J., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.04.019 · Cited by 58 · cited 6×
“R434* DUOX2 mutation itself are contributing to disease severity (6, 8, 9) (Table 1).”
BackgroundInfluentialMutation screening of DUOX2 in Chinese patients with congenital hypothyroidism
Fu, C., Zhang, S., Su, J., Luo, S., Zheng, H., Wang, J., Qin, H., Chen, Y., Shen, Y., Hu, X., et al. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0382-8 · Cited by 37
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“Moreover, the first CH patients with both DUOX1 and DUOX2 mutations have been reported, suggesting that CH can have a digenic cause (225).”
BackgroundSelf-citationDIAGNOSIS OF ENDOCRINE DISEASE: Congenital hypothyroidism: update and perspectives
Peters, C., van Trotsenburg, A. S. P., & Schoenmakers, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0383 · Cited by 162
Self-citationBuvelot, H., Jaquet, V., & Krause, K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9424-3_2 · Cited by 144
Sun, F., Zhang, J., Yang, C., Gao, G.-Q., Zhu, W., Han, B., Zhang, L., Wan, Y., Ye, X., Ma, Y., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1017 · Cited by 110
Congenital hypothyroidism: insights into pathogenesis and treatment
Cherella, C. E., & Wassner, A. J. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-017-0051-0 · Cited by 106
“More recently, the first evidence of a physiologic role for DUOX1 in humans was provided by a report of two siblings with homozygous inactivating mutations in both DUOX1 and DUOX2 associated with congenital hypothyroidism more severe than is typically observed in DUOX2 deficiency alone [17].”
BackgroundLiving on the Edge: ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target
Brandl, N., Seitz, R., Sendtner, N., Müller, M., & Gülow, K. (2025) · Antioxidants · doi:10.3390/antiox14081002 · Cited by 129
“Loss-of-function mutations in DUOX2 or in the maturation factors DUOXA1/2 impair H 2 O 2 supply and are a recognized cause of congenital hypothyroidism [33].”
Genetics and management of congenital hypothyroidism
Persani, L., Rurale, G., de Filippis, T., Galazzi, E., Muzza, M., & Fugazzola, L. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.05.002 · Cited by 82
Self-citationZou, M., Alzahrani, A. S., Al-Odaib, A., Alqahtani, M. A., Babiker, O., Al-Rijjal, R. A., BinEssa, H. A., Kattan, W. E., Al-Enezi, A. F., Al Qarni, A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02202 · Cited by 78
“Digenic biallelic DUOX1 and DUOX2 mutations have also been reported in CH (28).”
BackgroundEvaluation and management of the child with hypothyroidism
Leung, A. K. C., & Leung, A. A. C. (2019) · World Journal of Pediatrics · doi:10.1007/s12519-019-00230-w · Cited by 70
New genetics in congenital hypothyroidism
Stoupa, A., Kariyawasam, D., Muzza, M., de Filippis, T., Fugazzola, L., Polak, M., Persani, L., & Carré, A. (2021) · Endocrine · doi:10.1007/s12020-021-02646-9 · Cited by 59
“The first CH patients bearing both DUOX1 as well as DUOX2 mutations have been reported, suggesting a possible digenic cause of CH [20].”
BackgroundSelf-citationOligogenic Origin of Differences of Sex Development in Humans
Camats, N., Flück, C. E., & Audí, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051809 · Cited by 56
Genetics of congenital hypothyroidism: Modern concepts
Stoupa, A., Kariyawasam, D., Polak, M., & Carré, A. (2022) · Pediatric Investigation · doi:10.1002/ped4.12324 · Cited by 58
Defects in protein folding in congenital hypothyroidism
Targovnik, H. M., Scheps, K. G., & Rivolta, C. M. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110638 · Cited by 49
Iodine and Thyroid Maternal and Fetal Metabolism during Pregnancy
Mégier, C., Dumery, G., & Luton, D. (2023) · Metabolites · doi:10.3390/metabo13050633 · Cited by 52
“The energy needed for this oxidation is provided by hydrogen peroxide (H2O2), generated mainly by a dual oxidase 2 and additionally by a dual oxidase 1 [35,36].”
BackgroundDUOX Defects and Their Roles in Congenital Hypothyroidism
Deken, X. D., & Miot, F. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9424-3_37 · Cited by 44
MECHANISMS IN ENDOCRINOLOGY: The pathophysiology of transient congenital hypothyroidism
Peters, C. J., & Schoenmakers, N. A. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1278 · Cited by 49
“In contrast, a report describing digenic, homozygous DUOX2 and DUOX1 mutations in one family notes uncharacteristically severe CH in the affected siblings, consistent with perturbed compensatory mechanisms for H 2 O 2 production when both DUOX enzymes are disrupted (48).”
Self-citationStructure and genetic variants of thyroglobulin: Pathophysiological implications
Citterio, C. E., Rivolta, C. M., & Targovnik, H. M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111227 · Cited by 39
Wang, F., Zang, Y., Li, M., Liu, W., Wang, Y., Yu, X., Li, H., Wang, F., & Liu, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00237 · Cited by 34
“As recently reported (46), mutations of multiple genes cause phenotype aggravation because of the weakening of the attenuated compensation effect of related genes.”
BackgroundZebrafish duox mutations provide a model for human congenital hypothyroidism
Chopra, K., Ishibashi, S., & Amaya, E. (2019) · Biology Open · doi:10.1242/bio.037655 · Cited by 39
Salas-Lucia, F., Pacheco‐Torres, J., González-Granero, S., Canals, S., Obregón, M.-J., García‐Verdugo, J. M., & Berbel, P. J. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00031 · Cited by 26
“…causing neurological and psychiatric diseases, such as intellectual disability, spasticity, and disturbances of gait and coordination (Dussault and Ruel, 1987; Rovet et al., 1992; Rovet, 1999, 2002; Brown, 2012; Clairman et al., 2015; Krude et al., 2015; Léger, 2015; Aycan et al., 2017).”
BackgroundGrasberger, H., Noureldin, M., Kao, T. D., Adler, J., Lee, J. M., Bishu, S., Zaatari, M. E., Kao, J. Y., & Waljee, A. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-28586-5 · Cited by 23
Zhang, R., Sun, F., Chen, F., Fang, Y., Yan, C., Zhang, C.-R., Ying, Y., Wang, Z., Zhang, C.-X., Wu, F., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110761 · Cited by 24
NADPH Oxidases in Inflammatory Bowel Disease
Stenke, E., Bourke, B., & Knaus, U. G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9424-3_38 · Cited by 26
Park, K. (2021) · Genes · doi:10.3390/genes12060863 · Cited by 26
“might have a digenic cause; digenic DUOX1 and DUOX2 causative variants in cases with congenital hypothyroidism have been reported [36].”
BackgroundStępniak, J., Lewiñski, A., & Karbownik‐Lewińska, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124063 · Cited by 22
“However, it is believed that it could function to overcome the lack of DUOX2 activity, at least under some still undefined circumstances [25].”
BackgroundStoupa, A., Carré, A., Polak, M., Szinnai, G., & Schoenmakers, N. A. (2025) · European Thyroid Journal · doi:10.1530/etj-24-0348 · Cited by 28
Self-citationClinical and genetic investigation of 136 Japanese patients with congenital hypothyroidism
Tanaka, T., Aoyama, K., Suzuki, A., Saitoh, S., & Mizuno, H. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0433 · Cited by 22
“[25] reported CH patients with associated oligogenic mutations in DUOX2 and DUOX1.”
BackgroundGenetics of Gland-in-situ or Hypoplastic Congenital Hypothyroidism in Macedonia
Zdraveska, N., Kočova, M., Nicholas, A. K., Anastasovska, V., & Schoenmakers, N. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00413 · Cited by 24
“Oligogenicity may also modulate CH phenotype explaining the variable penetrance and expressivity of genetic defects observed in familial CH (18, 28, 34, 39, 40).”
BackgroundSelf-citationSánchez‐Ares, M., Cameselle‐García, S., Abdulkader, I., Rodríguez-Carnero, G., Beiras-Sarasquete, C., Puñal-Rodríguez, J. A., & Cameselle‐Teijeiro, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.829103 · Cited by 20
“DUOX2 mutations cause congenital hypothyroidism that may be phenotypically heterogeneous (90).”
BackgroundDual Oxidase System Genes Defects in Children With Congenital Hypothyroidism
Wang, F., Li, X., Ma, R., Zhao, D., & Liu, S. (2021) · Endocrinology · doi:10.1210/endocr/bqab043 · Cited by 21
Poncelet, L., Dumont, J.-E., Miot, F., & De Deken, X. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111620 · Cited by 18
“Furthermore, the combination of mutations in both Duox1 and Duox2 genes has been associated with a more severe phenotype of inherited hypothyroidism [9].”
BackgroundCongenital Hypothyroidism due to Oligogenic Mutations in Two Sudanese Families
Watanabe, Y., Bruellman, R., Ebrhim, R. S., Abdullah, M. A., Dumitrescu, A. M., Refetoff, S., & Weiss, R. E. (2018) · Thyroid · doi:10.1089/thy.2018.0295 · Cited by 18
“Regarding findings in family 2 with severe CH, digenic DUOX2 and DUOX1 mutations have been reported recently (6).”
BackgroundSalas-Lucia, F., Pacheco‐Torres, J., González-Granero, S., García‐Verdugo, J. M., & Berbel, P. J. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.00033 · Cited by 20
“…gland, causing neurological and psychiatric deficits, such as intellectual disability, spasticity, and disturbances in gait and co-ordination (Dussault and Ruel, 1987; Rovet et al., 1992; Rovet, 1999, 2002; Brown, 2012; Clairman et al., 2015; Krude et al., 2015; Léger, 2015; Aycan et al., 2017).”
Zheng, Z., Yang, L., Sun, C., Wu, J., Luo, F., Zhou, W., & Lu, W. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-7165 · Cited by 17
“A possible reason was raised in 2016 by Maruo et al., who investigated the prognosis of patients with CH due to DUOX2 mutations and raised the hypothesis that DUOX1 compensated the DUOX2 mutation in thyroid cells which produce H2O2 for tissue and coupling of tyrosine in the infancy and adult period.”
BackgroundInfluentialGeysels, R. C., Barquero, C. E. B., Martín, M., Peyret, V., Nocent, M., Sobrero, G. M., Muñoz, L., Signorino, M., Testa, G., Castro, R. B., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.868891 · Cited by 15
Giusti, N., Gillotay, P., Trubiroha, A., Opitz, R., Dumont, J.-E., Costagliola, S., & Deken, X. D. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110635 · Cited by 16
“Recently, combination of mutations in both DUOX1 and DUOX2 has been associated with a more severe phenotype of inherited hypothyroidism (Aycan et al., 2017).”
BackgroundBaz-Redón, N., Antolín, M., Clemente, M., Campos-Martorell, A., Mogas, E., Fernández‐Cancio, M., Zafon, E., García‐Arumí, E., Soler, L., González-Llorens, N., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158473 · Cited by 13
Rudolf, A. M., Wu, Q., Li, L., Wang, J., Huang, Y., Togo, J., Liechti, C., Li, M., Niu, C., Nie, Y., et al. (2021) · National Science Review · doi:10.1093/nsr/nwab125 · Cited by 13
“Some previously discovered mutations in DUOX2, or its maturation factor DUOXA, in mice [4,10] and humans [5,9,11-14] have been linked to goiter, dwarfism and congenital hypothyroidism.”
BackgroundLouzada, R. A. N., Corre, R., Hassani, R. A. E., Hecht, F., Cazarin, J., Buffet, C., de Carvalho, D. P., & Dupuy, C. (2018) · Thyroid · doi:10.1089/thy.2017.0596 · Cited by 12
“This concept is supported by the report of digenic mutations in both DUOX1 and DUOX2 , which are associated with a severe CH phenotype (5).”
Li, L., Li, X., Wang, X., Han, M., Zhao, D., Wang, F., & Liu, S. (2022) · Endocrine · doi:10.1007/s12020-022-03188-4 · Cited by 12
Park, J., Choi, T., Kim, O.-H., Hong, T. I., Kim, W., Lee, W., & Kim, C. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.01.004 · Cited by 13
Pio, M. G., Molina, M. F., Siffo, S., Chiesa, A. E., Rivolta, C. M., & Targovnik, H. M. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111124 · Cited by 18
DUOX1 and DUOX2, DUOXA1 and DUOXA2
Miot, F., & Deken, X. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-23752-2_14 · Cited by 8
Barquero, C. E. B., Martín, M., Geysels, R. C., Peyret, V., Papendieck, P., Masini-Repiso, A. M., Chiesa, A. E., & Nicola, J. P. (2021) · Thyroid · doi:10.1089/thy.2021.0344 · Cited by 8
Génétique de l’hypothyroïdie congénitale
Stoupa, A., Kariyawasam, D., Polak, M., & Carré, A. (2022) · médecine/sciences · doi:10.1051/medsci/2022028 · Cited by 7
Opazo, M. C., Rivera, J. C. A., González, P. A., Bueno, S. M., Kalergis, A. M., & Riedel, C. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.679002 · Cited by 7
“described two patients with severe CH that have biallelic mutations in DUOX2 and DUOX1, suggesting that DUOX1 can replace the function of DUOX2 when this enzyme is not available (48).”
BackgroundThe role of DUOXA2 in the clinical diagnosis of paediatric congenital hypothyroidism
Du, J., Yang, Y., Wei, D., Wu, J.-J., Tian, C., Hu, Q., Bian, H., Chen, C., & Zhai, X. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2440121 · Cited by 6
“DUOX2 is thought to be the dominant iso-enzyme in the thyroid, as evidenced by its higher thyroi-dal expression levels and mutations in the human DUOX2 and DUOXA2 genes have been related to temporary or persistent CH, according to some clinical researches [18– 20].”
Genetic Causes of Congenital Hypothyroidism
Schoenmakers, N. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65336-9 · Cited by 4
Self-citationDjerbib, S., Grasberger, H., Goossens, S., Haigh, J. J., Haenebalcke, L., Pieters, T., Kero, J. T., Miot, F., & Deken, X. D. (2025) · Thyroid · doi:10.1177/10507256251388325 · Cited by 3
“3,14,15 The phenotype severity could re fl ect the loss of compensatory mechanism played by DUOX1.”
Variation spectra in mild isolated hyperthyrotropinemia: pilot cohort and systematic review
Ricci, V., Masnata, M. E., Gonzalez, M. D. V., Enacán, R. E., Izquierdo, A., Adrover, E., Azcoiti, M. E., Sansó, G., Scaglia, P. A., Rivolta, C. M., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1612450 · Cited by 1
Stoupa, A., Carré, A., Polak, M., & Szinnai, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-812531-1.00013-0 · Cited by 1
Gene mutations in children with permanent congenital hypothyroidism in Yunnan, China
Gong, Y., Zhang, Y., Fan, L. I. U., Baosheng, Z., Zhou, X., Ying, C. H. A. N., Li, S., & Li, L. (2022) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2022-0199 · Cited by 1
Biochemical and molecular evaluation of thyroid gland disorders in children
Magne, F., Vliet, G. V., & DELVIN, E. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817962-8.00035-4
van Trotsenburg, A. S. P., & Zwaveling‐Soonawala, N. (2022) · doi:10.1093/med/9780198870197.003.0174
Genetic causes of congenital hypothyroidism
Schoenmakers, N. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00172-2
Self-citationZhang, Y., Wang, S., Li, A., Zhao, W., Xia, F., Chan, Y., Lin, J., Zhou, X., Li, S., Feng, N., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1640108 · Cited by 1
Arshad, M., Hanif, A., Yasin, N., Khan, A. A., Husnain, A., Stanikzai, H., Ayub, A., Meraj, H., Amin, A., & Hamza, A. (2026) · Cureus · doi:10.7759/cureus.100944
“Few studies exist that systematically examine bilirubin levels between hypothyroid and euthyroid neonates, although CH shows a genetic connection to DUOX2 mutations in 21-45% of cases [16,17].”
Gene expression analysis for feed efficiency trait in liver tissue of lactating Girolando cows
Faza, D. R. D. L. R., Campos, M. M., Tomich, T. R., Machado, F. S., Pereira, L. R., Domingues, R., Franco, A. L., Martins, M. F., Panetto, J. C. D. C., da Silva, M. V. G. B., et al. (2025) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2025-0036
“Mutations in the DUOX2 and DUOXA2 genes have been described in patients with congenital hypothyroidism in humans (Zamproni et al. , 2008; Park et al. , 2016; Aycan et al. , 2017).”
Lebsir, D. (2018) · theses.fr (ABES) · doi:10.70675/1b094217z02a5z4813z9532z182cbdd01968 · Cited by 1
Köprülü, Ö., Acar, S., Uzman, C. Y., Erbaş, İ. M., Nalbantoğlu, Ö., Hazan, F., Gürsoy, S., Korkmaz, H. A., & Özkan, B. (2026) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2026-0119 · Cited by 1
“Also, both DUOX2 and DUOXA2 mutations may be associated with severe and permanent CH [4, 17, 19].”
Metadata
- Authors
- Aycan, Z., Cangul, H., Muzza, M., Bas, V. N., Fugazzola, L., Chatterjee, V. K., Persani, L., & Schoenmakers, N.
- Affiliations
- Dr Sami Ulus Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hastanesi (TR)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- University of Milan (IT)
- University of Cambridge (GB)
- Corresponding author
- Schoenmakers, Nadia
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-06-16
- Volume
- 102
- Issue
- 9
- Pages
- 3085-3090
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5587079
- OpenAlex
- W2626775677
- Cited by
- 60
- References
- 12
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 3 · 2023: 2 · 2022: 8 · 2021: 8 · 2020: 9 · 2019: 9 · 2018: 11 · 2017: 1
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (100585, 095564/Z/11/Z, /Z/11/Z, 095564, 100585/Z/12/Z)
- National Institute for Health and Care Research (NF-SI-0514-10176)
- Ministero della Salute (RF-2010-2309484, RF 2010, 2010-2309484)
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (214S637)
- Medical Research Council (MC_PC_12012)
- NIHR Cambridge Biomedical Research Centre
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- congenital hypothyroidism, DUOX1, DUOX2, thyroid peroxidase, hydrogen peroxide, thyroid hormone synthesis, aberrant splicing, loss-of-function mutations, phenotypic variability
- MeSH terms
- Dual Oxidases, Congenital Hypothyroidism, Female, Genotype, Humans, Infant, Infant, Newborn, Male, Pedigree, Phenotype, Retrospective Studies, Severity of Illness Index, Thyroid Function Tests, Genetic Variation, Cohort Studies, Codon, Nonsense, NADPH Oxidases, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.